February 5, 2026 · Form 4 insider transaction
Lockshin Curtis bought 16,600 shares of PHIO PHARMACEUTICALS CORP at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant.; Includes shares of common stock underlying unvested restricted stock units.; The number of reported securities has been adjusted to reflect prior reverse stock splits.